Warsaw’s AI-first primary healthcare startup Jutro Medical raises €24 million Series A extension

Warsaw-based primary healthcare startup Jutro Medical has raised €24 million to scale its AI-enabled primary care rollup. 

This Series A extension round was led by Warsaw Equity Group, with participation from Vinci, naturalX Health Ventures, Fluent Ventures, Aternus, KAYA VC, and Inovo VC. A debt component from mBank and Orbit Capital is also included in this round. This new capital extends the company’s previously announced Series A, bringing its total to €36 million.

“By running our own clinics on our own software, we’ve learned firsthand which tasks can be handled by AI. Instead of hiring more staff, we now build AI agents that do the same work – freeing clinicians to practice medicine, not paperwork. These agents already manage thousands of patients interactions every month,” said Adam Janczewski, founder and CEO of Jutro Medical.

Founded in 2020 by Janczewski, Jutro Medical is an AI-first primary care operator integrating online and offline care, and has its own EHR, scalable clinic operations and AI agents. Its telemedicine platform and app offer virtual consultations, prescriptions, referrals, lab results and the ability to request medical leave online for less complex cases. For more immediate or complex cases, patients can be seen in person at Jutro Medical’s proprietary clinics, often by the same practitioner they have been consulting virtually, ensuring continuity of care.

Jutro Medical claims to be the first operator in Europe to apply the AI rollup model to primary care at scale. According to the company, it spent its first four years focused on building its proprietary electronic health record system, laying the software and data foundations for all of its clinics.

This enabled the company to build an AI layer on top of this software and data foundation quickly and easily. With Jutro Medical’s AI agents taking over the administrative work, the doctors are free to focus on the patient and clinical decisions. However, the company reveals that the use of AI is completely opt-in, and patients can always choose a traditional appointment. Jutro Medical plans to continue developing new AI agents with this new capital. 

Bartosz Drabikowski, CEO of Vinci, said, “For us, this is a strategically important investment in the healthcare sector, and the key factor behind our decision was Jutro Medical’s mission to improve access to high-quality healthcare in Poland and across Europe. 

“Through the practical use of AI agents in everyday clinical operations, the company enables doctors to spend more time with patients, reduces waiting times and improves access to medical services. 

“The fact that these solutions are already being implemented at scale and deliver clear value for both patients and clinicians was an important consideration in our investment decision, and we are pleased to support Adam and his team in the next stage of growth.”

Another core part of the company’s value proposition is its unified operating model. Jutro Medical acquires clinics and brings them onto a unified operational and technological platform, giving each location access to the same EHR, workflow system and AI agents. The company says this approach ensures consistent quality, speeds up integration, and improves margins across its network.

This year, Jutro has added nine clinics to its network, and says it is on track to complete around 20 acquisitions annually. The company currently provides care to 120,000 patients across Poland, and after 500,000 visits, reported an average visit rating on a 1–5 scale of 4.94. Its NPS stands at 86, according to the company.

The new capital will support further clinic acquisitions in Poland and enable the company to expand its rollup model by buying and integrating primary care clinics across Europe. 

Jan Szumada, Investment Manager at Warsaw Equity Group, said, “Primary care is undergoing significant structural change across Europe, with thousands of small GP practices approaching retirement each year. 

“Jutro Medical is capitalising on this opportunity – nearly quadrupling its revenue year over year while keeping EBITDA around break-even – a rare combination in this market. 

“At WEG, we invest in companies whose technology delivers meaningful customer value and reshapes their industries. We’re excited to back a team that is proving the AI-rollup strategy works and support them as they build a pan-European operator targeting more than €1 billion in revenue.”

According to the company, it is growing 270% year over year, and in the past month, nearly 1,500 doctor visits were supported by AI. Its goal is to establish a pan-European primary care operator setting a new standard for publicly funded care.

The post Warsaw’s AI-first primary healthcare startup Jutro Medical raises €24 million Series A extension appeared first on EU-Startups.